Smith M K, Kimmel G L, Kochhar D M, Shepard T H, Spielberg S P, Wilson J G
Teratog Carcinog Mutagen. 1983;3(6):461-80. doi: 10.1002/1520-6866(1990)3:6<461::aid-tcm1770030603>3.0.co;2-i.
The Consensus Workshop on In Vitro Teratogenesis Testing recommended that test validation be facilitated by a listing of agents with defined teratogenicity; subsequently, a panel was convened to review and select such agents. This communication established a list of 47 compounds or conditions which demonstrate a wide range of teratogenicity in vivo. The agents were chosen primarily on the strength of the literature base denoting their in vivo effects. The tables note a number of general biological and toxicological characteristics for each agent, and the details of representative in vivo teratology studies are summarized and referenced. This list is intended to serve as a base for in vitro teratogenesis test validation and should prove useful in developing and identifying those systems which will contribute to a more effective testing program.